Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Keeping Loved Ones Active and Healthy During the Holidays with VARON Oxygen Concentrators 2025-12-12 23:16
/DISREGARD RELEASE: Ractigen Therapeutics/ 2025-12-12 23:10
United Imaging Intelligence at RSNA 2025: Reshaping Medicine with AI Agents 2025-12-12 22:00
Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits 2025-12-12 22:00
Global Attention: POGMENT Biomimetic Collagen "Stable Triple-Helix Breakthrough" --Unconventional and Astonishing 2025-12-12 21:46
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy 2025-12-12 21:35
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD) 2025-12-12 20:00
Smartee Strengthens Clinical Engagement in the DACH Region with First GS Summit in Cologne and Presence at TPAO Congress 2025-12-12 17:26
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab 2025-12-12 10:31
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity 2025-12-12 08:00
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial 2025-12-12 04:49
Datasea Announces Breakthrough in Acoustic-Driven Brain-Computer Interface Technology 2025-12-11 22:30
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 2025-12-11 21:00
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases 2025-12-11 14:00
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025 2025-12-11 09:53
Samsung Biologics recognized as a global leader in water security 2025-12-11 07:30
DNV RECEIVES CMS APPROVAL FOR NEW AMBULATORY SURGERY CENTERS ACCREDITATION PROGRAM 2025-12-10 22:32
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+ 2025-12-10 21:00
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody 2025-12-10 08:26
PhyxUp Health Leads Innovation in US Rehabilitation Market with AI-Powered Remote Therapeutic Monitoring(RTM), Launches $1M Seed Funding Round 2025-12-10 00:00
1 2 3 4 5 888